Poland· PL-100527126
PSMAtrace
A gallium (68ga) gozetotide product containing gozetotidum, registered in Poland by Billev Pharma ApS. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Gallium (68ga) gozetotide is registered in 11 of 19 countries.
Countries holding a registration under ATC V09IX14 (gallium (68ga) gozetotide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Gallium (68ga) gozetotide · ATC V09IX14
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Gozetotidum
- Manufacturer
- Billev Pharma ApS
- Country
- Poland (PL)
- ATC code
- V09IX14
- ATC class
- Gallium (68Ga) gozetotide
- Defined daily dose
- 140 MBq, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991602277
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09IX14
Gallium (68ga) gozetotide, as other registers publish it.
- FinlandIlluccixTelix Innovations
- DenmarkIlluccixTelix Innovations
- CanadaILLUCCIXTELIX PHARMACEUTICALS (US), INC.
- CzechiaILLUCCIXTelix Innovations, Herstal
- CzechiaILLUCCIXTelix Innovations, Herstal
- NetherlandsIlluccix 25 microgram kit voor radiofarmaceutisch preparaatTelix Innovations S.A.
- IrelandIlluccix 25 micrograms kit for radiopharmaceutical preparationTelix Innovations
- BelgiumIlluccix 25 µgTelix Innovations
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc2bf2ac-33e5-4736-9dce-3a95d2610912 GET /v1/drugs/dc2bf2ac-33e5-4736-9dce-3a95d2610912?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zestaw do sporządzania preparatu radiofarmaceutycznego",
"source": "urpl",
"strength": "10 mcg",
"packaging": "05909991602277 ¦ Rpz ¦ 165867\n5 fiol. 10 ml",
"substance": "Gozetotidum 10 mcg",
"common_name": "Gozetotidum",
"pl_product_id": "100527126",
"pozwolenie_nr": "29722",
"auth_procedure": "MRP",
"authorisation_validity": "2031-05-25"
}See everything about gallium (68ga) gozetotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.